Evidence map›Paper›PMID 41693048›Full record

ArticleBritish journal of haematology2026

Atypical mast cells and multiple myeloma: An ambiguous alliance with diagnostic implications.

Jean-Baptiste Rieu, Anaïs Schavgoulidze, Alban Canali, Laetitia Largeaud, Aurore Perrot, Charlotte Syrykh

Abstract read
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jean-Baptiste RieuLaboratoire d'Hématologie, Centre Hospitalo-Universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Université de Toulouse, UPS, Toulouse, France.ORCID https://orcid.org/0000-0002-0950-979X
Anaïs SchavgoulidzeLaboratoire d'Hématologie, Centre Hospitalo-Universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Université de Toulouse, UPS, Toulouse, France.ORCID https://orcid.org/0000-0002-5526-4279
Alban CanaliLaboratoire d'Hématologie, Centre Hospitalo-Universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Université de Toulouse, UPS, Toulouse, France.ORCID https://orcid.org/0000-0002-1609-3307
Laetitia LargeaudLaboratoire d'Hématologie, Centre Hospitalo-Universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Université de Toulouse, UPS, Toulouse, France.
Aurore PerrotService d'Hématologie, Centre Hospitalo-Universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Université de Toulouse, UPS, Toulouse, France.ORCID https://orcid.org/0000-0003-0131-8689
Charlotte SyrykhLaboratoire d'Anatomopathologie, Centre Hospitalo-Universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Université de Toulouse, UPS, Toulouse, France.ORCID https://orcid.org/0000-0002-3201-6109

Funding

Centre Hospitalier Universitaire de Toulouse
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41693048
PMCPMC12995527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.